T/CBPIA 0017-2025 Active Group standards

T/CBPIA 0017-2025 Technical Guidelines for Repeated Dose Toxicity Studies of Oligonucleotide Therapeutics

T/CBPIA 0017-2025 Technical Guidelines for Repeated Dose Toxicity Studies of Oligonucleotide Therapeutics

Publish Date: 2025-12-29 Implement Date: 2026-01-28 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/CBPIA 0017-2025
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: Biological products and blood products
ICS Name: Drugs
Publish Date: 2025-12-29
Implement Date: 2026-01-28

Scope

Please note that some content of this document may involve patents. The issuing authority of this document does not assume responsibility for identifying patents. The main content of this document includes: purpose and scope, terms and definitions, considerations for non-clinical safety studies, repeated administration toxicity studies, conversion of clinical starting doses, and references.

Development Information

Related Standards

Contact Us